Evidence map›Paper›PMID 25184477›Full record

ArticlePloS one2014

Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.

Kaori Suenaga, Shuji Kitahara, Yasuhiro Suzuki, Miho Kobayashi, Sachiko Horie, Junichi Sugawara, Nobuo Yaegashi, Yasufumi Sato

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Kaori SuenagaDepartment of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan; Department of Obstetrics & Gynecology, Tohoku University School of Medicine, Aoba-ku, Sendai, Miyagi, Japan.
Shuji KitaharaDepartment of Anatomy and Developmental Biology, Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan.
Yasuhiro SuzukiDepartment of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan.
Miho KobayashiDepartment of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan.
Sachiko HorieDepartment of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan.
Junichi SugawaraDepartment of Obstetrics & Gynecology, Tohoku University School of Medicine, Aoba-ku, Sendai, Miyagi, Japan; Tohoku Medical Megabank Organization, Tohoku University, Aobaku, Sendai, Miyagi, Japan.
Nobuo YaegashiDepartment of Obstetrics & Gynecology, Tohoku University School of Medicine, Aoba-ku, Sendai, Miyagi, Japan; Tohoku Medical Megabank Organization, Tohoku University, Aobaku, Sendai, Miyagi, Japan.
Yasufumi SatoDepartment of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Aoba-ku, Sendai, Miyagi, Japan.
Tohoku University · JPTokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vasohibin-1 (VASH1) and vasohibin-2 (VASH2), the 2 members of the vasohibin family, have been identified as novel regulators of angiogenesis. VASH1 ceases angiogenesis, whereas VASH2 stimulates sprouting. Here we characterized their functional role in the placenta. Immunohistochemical analysis of human placental tissue clarified their distinctive localization; VASH1 in endothelial cells and VASH2 in trophoblasts. We then used a mouse model to explore their function. Wild-type, Vash1((-/-)), and Vash2((-/-)) mice on a C57BL6 background were used in their first pregnancy. As expected, the fetal vascular area was increased in the Vash1((-/-)) mice, whereas it was decreased in the Vash2((-/-)) mice relative to wild-type. In addition, we noticed that the Vash2((-/-)) mice at 18.5dpc displayed thinner villi of the labyrinth and larger maternal lacunae. Careful observation by an electron microscopy revealed that the syncytiotrophoblast formation was defective in the Vash2((-/-)) mice. To test the possible involvement of VASH2 in the syncytiotrophoblast formation, we examined the fusion of BeWo cells, a human trophoblastoid choriocarcinoma cell line. The forskolin treatment induced the fusion of BeWo cells, and the knockdown of VASH2 expression significantly inhibited this cell fusion. Conversely, the overexpression of VASH2 by the infection with adenovirus vector encoding human VASH2 gene significantly increased the fusion of BeWo cells. Glial cell missing-1 and endogenous retrovirus envelope glycoprotein Syncytin 1 and Syncytin 2 are known to be involved in the fusion of trophoblasts. However, VASH2 did not alter their expression in BeWo cells. These results indicate that VASH1 and VASH2 showed distinctive localization and opposing function on the fetoplacental vascularization. Moreover, our study shows for the first time that VASH2 expressed in trophoblasts is involved in the regulation of cell fusion for syncytiotrophoblast formation.

Indexed as

Neovascularization, PhysiologicAdenoviridaeAdultAngiogenic ProteinsAnimalsCell Cycle ProteinsCell FusionCell Line, TumorColforsinDNA-Binding ProteinsFemaleGene Expression RegulationGene Products, envGenetic VectorsHumansMiceAngiogenic ProteinsCell Cycle ProteinsColforsinDNA-Binding ProteinsERVFRD-1 protein, humanGCM1 protein, humanGene Products, envNuclear ProteinsPregnancy ProteinssyncytinTranscription FactorsVASH1 protein, humanVASH2 protein, human

Identifiers

PMID25184477
PMCPMC4153575
OpenAlexW1967740677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.